AEVIS VICTORIA SA (AEVS.SW) – Publication of the 2023 revenue - Seite 3

AEVIS’ consolidated revenue, a less representative indicator for an investment company, amounted to CHF 953.0 million (2022: CHF 1.14 billion), down due to the deconsolidation of Réseau de l'Arc and the absence of M&A transactions affecting the result. On a like-for-like basis, organic growth stood at 1.5%.

AEVIS will publish its 2023 Annual Report on Thursday 28 March 2024. The investment company expects a net loss after depreciation, amortization and financial expenses of between CHF 35 and 45 million.

For further information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey, [e-mail], [phone] or [phone]
Séverine Van der Schueren, [e-mail], [phone]

AEVIS VICTORIA SA - Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network SA (80%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, MRH Switzerland AG, a luxury hotel group managing eleven luxury hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.

---

End of Inside Information

---

1863565  21-March-2024 CET/CEST

The AEVIS VICTORIA Stock at the time of publication of the news with a fall of -0,30 % to 16,65EUR on Lang & Schwarz stock exchange (20. März 2024, 22:59 Uhr).